Tumor Infiltrating Lymphocytes Global Market Report 2023: Sector to Reach $15.56 Billion by 2027 at a 13.7% CAGR
May 23, 2023 04:53 ET
|
Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tumor infiltrating...
CAR T-Cell Therapy Market to be Worth $51.6 Billion by 2030 - Exclusive Report by Meticulous Research®
May 16, 2023 10:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, May 16, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘CAR T-Cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene...
Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer
May 12, 2023 04:00 ET
|
AKAMPION
ROTTERDAM, May 12, 2023 - Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery and development of next-generation TCR-T therapies against solid tumors, today announces the...
Cancer Immunotherapy Market to reach USD 261.7 Bn in 2031, expanding at a CAGR of 13.6%: TMR Report
May 11, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global cancer immunotherapy market is projected to flourish at a CAGR of 13.6% from 2022 to 2031. As per the report...
Cancer Immunotherapy Global Market to 2032: Rising Cancer Incidence is Expected to Propel the Sector
April 26, 2023 09:33 ET
|
Research and Markets
Dublin, April 26, 2023 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific Advisory Board
April 25, 2023 04:00 ET
|
AKAMPION
- Renowned immunology expert from MD Anderson Cancer Center to lead seasoned group of scientific advisors Schlieren (Zurich Area), Switzerland, and Gaithersburg, MD, USA – April 25, 2023 –...
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
April 12, 2023 08:00 ET
|
AKAMPION
Berlin, Germany & Zurich, Switzerland – April 12, 2023 -- ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material...
Cancer Immunotherapy Market Size ($674 Bn by 2032 at 13.8% CAGR) Global Analysis by Market.us
March 28, 2023 07:40 ET
|
Market.Us
New York, March 28, 2023 (GLOBE NEWSWIRE) -- The Cancer Immunotherapy Market size accounted for USD 191 billion in 2022 and growth is estimated to accelerate at a CAGR of 13.8%, registering an...
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients
March 23, 2023 07:55 ET
|
Evaxion Biotech
Evaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapy This potentially enables treatment for patients with cold tumors, normally unresponsive to...
Evaxion Biotech to announce clinical data for the personalized DNA cancer vaccine EVX-02 at the 2023 American Association for Cancer Research Annual Meeting (AACR)
March 14, 2023 16:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, March 14, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of...